Precision Medicine aims to target the right drug, to the right patient, at the right dose and the right time. Precision Medicine is a cutting-edge field of innovation that improves disease outcome by tailoring treatments to characteristics of patients.
Precision Medicine improves the accuracy of diagnosis and prognosis, refines the selection of treatment, and increases therapeutic efficacy whilst decreasing the likelihood of side-effects. This approach triangulates between lots of data points: genes, proteins, other biomarkers, general health and phenotypic data, to place patients into stratified populations.
Precision medicine is an exciting and burgeoning area of health research that presents both economic and health benefits. The Health Team at Innovate UK KTN supports companies of various sizes, working across the sub-sectors of Precision Medicine. Precision Medicine is a particularly diverse and interdisciplinary area, and fruitful collaboration is crucial to innovation and enterprise. Innovate UK KTN is uniquely placed at the crossroads of multiple stakeholders in different sectors and facilitates key partnerships to advance this area of innovation forwards.
Flexible, agile, scalable and sustainable medicines manufacturing
Opens: 26/09/2023 Closes: 22/11/2023
UK registered organisations can apply for a share of up to £5m for development and implementation of technologies for medicines development and manufacture.
Canada-UK: Biomanufacturing of Biologics and Advanced Therapies
Opens: 26/06/2023 Closes: 17/10/2023
UK registered organisations can apply for a share of up to £3.5m to collaborate with Canadian SMEs on joint R&D to innovate in biomanufacturing biologics and advanced therapies.
Biomedical Catalyst 2023 Round 2: Industry-led R&D
Opens: 20/09/2023 Closes: 08/11/2023
UK registered SMEs can apply for a share of up to £20 million to develop innovative solutions to health and healthcare challenges.
Related Events and Recordings
Pilot accelerators launched to support the development of early-stage health and life science innovation in the UK
We are pleased to announce our pilot accelerators, in collaboration with the Medical Research Council (MRC), which will allow spinouts, start-ups, and entrepreneurial minded academics to test their ideas and develop concepts with support from key stakeholders from the innovation ecosystem.
Exploring Microbiome Innovation: Insights from the Microbiome One Health Conference
Over 100 microbiome researchers and innovators gathered in Glasgow in March 2023 for the sold-out Microbiome One Health Conference, organised by members of the Innovate UK KTN Microbiome Innovation Advisory Board and the Health and AgriFood teams.
Programmes related to Precision Medicine
Medimap: End-to-end medicines supply chain map
Medimap is a new interactive reference tool for the UK medicines sector, mapping and categorising over 3,000 sites of organisations engaged in or supporting the end-to-end supply chain for medicines.
Health Funding Map
The map was developed by Innovate UK KTN and the BioIndustry Association (BIA) with the help of a wide range of funders. It helps in the navigation of the complicated world of health innovation funding.
Transforming Medicines Manufacturing
Innovate UK’s Medicines Manufacturing programmes aim to drive the de-risking and adoption of highly innovative flexible, agile and scalable manufacturing technologies through a culture of collaboration that will drive the growth of this critically important manufacturing sector.